Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations. [electronic resource]
Producer: 20160122Description: 992-7 p. digitalISSN:- 1096-8652
- Adolescent
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- CCAAT-Enhancer-Binding Proteins -- genetics
- Cytogenetic Analysis
- DNA (Cytosine-5-)-Methyltransferases -- genetics
- DNA Methyltransferase 3A
- Female
- Gene Expression
- Hematopoietic Stem Cell Transplantation
- Humans
- Leukemia, Myeloid, Acute -- genetics
- Male
- Middle Aged
- Multivariate Analysis
- Mutation
- Nuclear Proteins -- genetics
- Nucleophosmin
- Prognosis
- Remission Induction
- Retrospective Studies
- Survival Analysis
- Transplantation, Homologous
- fms-Like Tyrosine Kinase 3 -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.